Frankfurt am Main, Germany – March 4, 2024

ICIG has successfully closed the acquisition of a majority stake in Vasant Chemicals, a renowned Indian company specializing in the production of Specialty Chemicals and Pharma Intermediates. The company is set to be integrated into the WeylChem Group the Fine Chemicals platform of ICIG. This acquisition is a key component of WeylChem’s strategic initiative to expand its presence in the global specialty chemicals market. This strategic alliance also marks a significant milestone in Vasant Chemical’s mission to expand its global footprint and enhance its value proposition for customers worldwide.

Vasant Chemicals, headquartered in Hyderabad, India, brings 40+ years of expertise to the WeylChem Group. With state-of-the-art manufacturing facilities in Hyderabad (Jeedimetla) and Visakhapatnam (Atchutapuram), the company specializes in the production of specialty chemicals and pharmaceutical intermediates and exports its products under long-term contractual agreements, reflecting the company’s dedication to fostering long-lasting partnerships and stable customer relationships.

“By integrating the expertise, resources, and technologies of both companies, the acquisition aligns with our strategic goal to create long-term value for our customers, employees, and stakeholders.” states Dr Andreas Maier, CEO of the WeylChem platform convinced of the strategic fit of the acquisition. “It allows WeylChem to directly participate in the fast-growing Indian market and adds a manufacturing and distribution base in Asia. Vasant Chemicals aligns seamlessly with WeylChem’s commitment to support the success of our customers with expertise and dedication.”

“This strategic transaction marks a significant step forward in Vasant Chemical’s vision to be a Global Multidimensional organization fostering global partnerships and unlocking value for its stakeholders. We are confident that the synergies between our organizations will drive operational efficiencies and unlock new growth opportunities. By leveraging our collective strengths, we will continue to deliver value-added solutions that empower our customers to achieve their business objectives“ states G.K.B Chowdary representing the former majority owner who will still hold a minority participation.

Ambit Pvt. Ltd. acted as the exclusive financial advisor to Vasant Chemicals for this transaction. PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft and Deloitte Touche Tohmatsu India LLP acted as the financial due diligence advisors to ICIG and Vasant Chemicals, respectively. Dentons Link Legal and S&R Associates acted as the legal counsels to ICIG and Vasant Chemicals, respectively.

About International Chemical Investors Group (ICIG): International Chemical Investors is a privately owned industrial group with sales in excess of €4.6 billion and more than 6,200 employees worldwide operating 42 production sites in Europe and the US. ICIG is focusing on five main platforms: Fine Chemicals under the WeylChem brand, Care Chemicals (Catexel), Chlorovinyls (VYNOVA), Compounds (BENVIC), Hydrocarbons & Solvents (HCS) brand, and Enterprises, which comprises several specified companies.For more information, please visit

About WeylChem Group: WeylChem Group is the fine chemistry platform of ICIG. With nine companies in Europe and North America, WeylChem employs around 1,250 professionals. The group is a global leader in the custom manufacturing of specialty chemicals, providing customers with a broad range of advanced intermediates and reagents for various applications.

About Vasant Chemicals: Vasant Chemicals is a privately held company based in Hyderabad, India, specializing in the manufacturing of Specialty Chemicals and Pharma Intermediates. With over four decades of industry experience, the company is recognized for its commitment to excellence, innovation, and ethical business practices.

For further information, please contact: Sibel Cumcu, ICI Holding SE


› Homepage
› Our Approach
› Our Investments
› News
› Sitemap
› Contact


› Who we are
› WeylChem

› Catexel

› Vynova

› Benvic

› HCS Group

› Enterprises



Goetheplatz 5-7
D-60313 Frankfurt
Phone: +49 (69) 506 999-0
Fax: +49 (69) 506 999-11

E-Mail: info @